309 related articles for article (PubMed ID: 5527958)
41. Combined live measles, mumps, and rubella virus vaccines.
Buynak EB; Weibel RE; Whitman JE; Stokes J; Hilleman MR
JAMA; 1969 Mar; 207(12):2259-62. PubMed ID: 5818433
[No Abstract] [Full Text] [Related]
42. [Issues related to rubella, measles and epidemic parotiditis in the Russian Federation].
Zverev VV; Iuminova NV
Vopr Virusol; 2004; 49(3):8-11. PubMed ID: 15188648
[TBL] [Abstract][Full Text] [Related]
43. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
Zäch K; Nicoara C; Germann D; Matter L
Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
[TBL] [Abstract][Full Text] [Related]
44. [Vaccination against measles, mumps and German measles. II. Socio-economic analysis].
Bjerregaard P; Pedersen KM; Kamper-Jørgensen F; Koch C; Pedersen FK; Wagner AL; Zoffmann H
Ugeskr Laeger; 1985 Sep; 147(38):3017-22. PubMed ID: 4071750
[No Abstract] [Full Text] [Related]
45. [Measles, mumps and rubella vaccination status of school beginners in Munich].
Markuzzi A; Schlipköter U; Weitkunat R; Meyer G
Soz Praventivmed; 1997; 42(3):133-43. PubMed ID: 9334085
[TBL] [Abstract][Full Text] [Related]
46. A randomized comparative trial in order to assess the reactogenicity and immunogenicity of a new measles mumps rubella (MMR) vaccine when given as a first dose at 12-24 months of age.
Gatchalian S; Cordero-Yap L; Lu-Fong M; Soriano R; Ludan A; Chitour K; Bock HL
Southeast Asian J Trop Med Public Health; 1999 Sep; 30(3):511-7. PubMed ID: 10774661
[TBL] [Abstract][Full Text] [Related]
47. Recommendations for using MMR vaccine in children allergic to eggs.
Khakoo GA; Lack G
BMJ; 2000 Apr; 320(7239):929-32. PubMed ID: 10787255
[No Abstract] [Full Text] [Related]
48. [Elimination of measles, mumps and rubella in Switzerland].
Herzog C
Soz Praventivmed; 1986; 31(6):326-9. PubMed ID: 3811611
[TBL] [Abstract][Full Text] [Related]
49. Rapid effect on endemic measles, mumps, and rubella of nationwide vaccination programme in Finland.
Peltola H; Karanko V; Kurki T; Hukkanen V; Virtanen M; Penttinen K; Nissinen M; Heinonen OP
Lancet; 1986 Jan; 1(8473):137-9. PubMed ID: 2867355
[TBL] [Abstract][Full Text] [Related]
50. Vaccination with combined live measles and rubella vaccines.
Ramos Alvarez M; Bessudo L
Rev Invest Salud Publica; 1972; 32(2):110-5. PubMed ID: 4584450
[No Abstract] [Full Text] [Related]
51. [Vaccination status and implementation of recommendations for vaccination with special reference to measles-mumps-rubella vaccination. 1995 program for school entrance].
Ziemer B; Blank K; Hennig R
Gesundheitswesen; 1998 May; 60(5):297-300. PubMed ID: 9676011
[TBL] [Abstract][Full Text] [Related]
52. [Simultaneous administration at different dosages of attenuated live virus vaccines against measles, mumps and rubella].
Ramos-Alvarez M; Bessudo L; Kenny MT; Jackson JE; Schwarz AJ
Bol Med Hosp Infant Mex; 1976; 33(4):875-86. PubMed ID: 782484
[No Abstract] [Full Text] [Related]
53. [Experimental study of simultaneous measles and mumps immunization].
Cernescu C; Strulovici D; Cepleanu M; Sorodoc Y; Copelovici Y
Stud Cercet Virusol; 1973; 24(5):363-8. PubMed ID: 4747455
[No Abstract] [Full Text] [Related]
54. Panel on immunizations.
Fulginiti VA; Nelson JD; McCracken GH
Pediatr Infect Dis; 1983; 2(3 Suppl):S64-9. PubMed ID: 6866802
[No Abstract] [Full Text] [Related]
55. Measles-mumps-rubella vaccine. Advance in immunization.
Barkin SZ; Barkin RM
Rocky Mt Med J; 1975 Jun; 72(6):247-50. PubMed ID: 1145029
[No Abstract] [Full Text] [Related]
56. Long-term follow-up for immunity after monovalent or combined live measles, mumps, and rubella virus vaccines.
Weibel RE; Buynak EB; McLean AA; Hilleman MR
Pediatrics; 1975 Sep; 56(3):380-7. PubMed ID: 1161394
[TBL] [Abstract][Full Text] [Related]
57. [Mumps epidemic in vaccinated children in West Switzerland].
Ströhle A; Eggenberger K; Steiner CA; Matter L; Germann D
Schweiz Med Wochenschr; 1997 Jun; 127(26):1124-33. PubMed ID: 9312835
[TBL] [Abstract][Full Text] [Related]
58. Swedish experience of two dose vaccination programme aiming at eliminating measles, mumps, and rubella.
Böttiger M; Christenson B; Romanus V; Taranger J; Strandell A
Br Med J (Clin Res Ed); 1987 Nov; 295(6608):1264-7. PubMed ID: 3120971
[TBL] [Abstract][Full Text] [Related]
59. Clinical and serologic evaluation of measles, mumps, and rubella (HPV-77:DE-5 and RA 27/3) virus vaccines, singly and in combination.
Lerman SJ; Bollinger M; Brunken JM
Pediatrics; 1981 Jul; 68(1):18-22. PubMed ID: 7017582
[TBL] [Abstract][Full Text] [Related]
60. [Thrombocytopenic purpura after isolated or combined vaccination against measles, mumps and rubella].
Autret E; Jonville-Béra AP; Galy-Eyraud C; Hessel L
Therapie; 1996; 51(6):677-80. PubMed ID: 9164004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
